Skip to main content

Table 1 Demographic features of patients with chronic hepatitis C treated with interferon (IFN) in nine regions of Japan

From: Regional disparities in interferon therapy for chronic hepatitis C in Japan: a nationwide retrospective cohort study

 

All

Hokkaido/Tohoku

Kanto

Shin-etsu

Hokuriku

Tokai

Kinki

Chugoku

Shikoku

Kyushu

P-value

n

16854

2055

1142

781

1046

1170

3565

2599

716

3780

 

Age (years)a

57.9 ± 10.9

56.9 ± 10.5

56.5 ± 11.3

59.4 ± 10.1

60.2 ± 9.3

58.7 ± 10.4

57.3 ± 11.6

59.3 ± 10.7

57.8 ± 10.1

57.5 ± 11.1

<0.001b

The elderly (≥65 years) (%)

30.2

26.1

24.9

34.4

35.3

32.5

29.9

34.9

26.7

28.7

<0.001c

Gender male (%)

50.4

50.6

53.3

46.7

44.3

48.8

51.5

49.7

54.6

51.2

<0.001c

IFN-experienced cases (%)

25.2

25.4

18.8

26.1

28.7

22.3

23.7

28.8

31.2

24.4

<0.001c

HCV Genotype 1/2/3/undetermined (%)

63.5/34.7/ 0.2/1.7

64.2/32.8/ 0.0/2.9

56.4/42.0/ 0.1/1.5

68.5/29.4/ 0.0/2.1

67.3/30.9/0.0/1.8

63.1/35.1/ 0.2/1.6

65.0/32.1/ 0.4/2.5

64.2/34.9/ 0.4/0.5

56.7/41.9/ 0.1/1.3

62.5/36.4/ 0.0/1.0

<0.001c

  1. aAge is shown as mean ± standard deviation
  2. bKruskal–Wallis analysis
  3. cPearson’s χ2 test
  4. IFN, Interferon; HCV, Hepatitis C virus